Treating Covid-19 with monoclonal antibodies

(ABC 6 News) – Covid-19 remains a big problem, especially with the delta variant. But therapies continue to evolve at Mayo Clinic depending on the clinical condition of a patient and the risk factors.

Some drugs modulate the immune system that will reduce inflammation in the form of steroids.They have anti-body treatment in the form of Remdesivir.

There are also drugs that modulate the immune system that will reduce inflammation in the form of steroids.

"As long as the virus continues to circulate in the community, variants will emerge. Many of these variants will develop resistance against many of the treatments that we have available and this is the reason why vaccinate vaccinate vaccinate is what is being proposed from the public health standpoint so that we don’t get to that stage," Dr. Raymund Razonable Mayo Clinic Infectious Disease Expert said.

Eligibility criteria for the monoclonal antibody treatment are very wide and have expanded to anybody who is 12 years and older, slightly overweight or with no other medical conditions.